Clinical Trial Update: Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describes ongoing Phase 2/Phase 3 evaluation of avatrombopag for thrombocytopenia after haploidentical hematopoietic stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Thrombocytopenia, Stem Cell Transplant Complications | Phase 2, Phase 3 | Status: RECRUITING